Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) StudyMartin R. Wilkins, J. Simon R. Gibbs, Gideon Paul et al.|American Journal of Respiratory and Critical Care Medicine|2005Cited by 381
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery CellsJohn Wharton, Martin R. Wilkins, Julian Strange et al.|American Journal of Respiratory and Critical Care Medicine|2005Cited by 367
The Hybrid Algorithm for Treating Chronic Total Occlusions in EuropeJoren Maeremans, Joseph Dens, Margaret McEntegart et al.|Journal of the American College of Cardiology|2016Cited by 309
Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary HypertensionAbdelkrim Sebkhi, Martin R. Wilkins, Julian Strange et al.|Circulation|2003Cited by 256
Comparison of Characteristics and Complications in Men Versus Women Undergoing Chronic Total Occlusion Percutaneous InterventionVinoda Sharma, James Spratt, William Wilson et al.|The American Journal of Cardiology|2016Cited by 45